[HTML][HTML] A new CCCH-type zinc finger-related lncRNA signature predicts the prognosis of clear cell renal cell carcinoma patients

C Shen, Z Chen, J Jiang, Y Zhang, W Xu, R Peng… - Frontiers in …, 2022 - frontiersin.org
Background: Clear cell renal cell carcinoma (ccRCC) is the main component of renal cell
carcinoma (RCC), and advanced ccRCC frequently indicates a poor prognosis. The …

Identification of unique long non-coding RNAs as putative biomarkers for chromophobe renal cell carcinoma

G Wu, P Xia, S Yan, D Chen, L Xie, G Fan - Personalized Medicine, 2020 - Taylor & Francis
Aim: To investigate whether long non-coding RNAs (lncRNAs) can be utilized as molecular
biomarkers in predicting the occurrence and progression of chromophobe renal cell …

[HTML][HTML] Prognosis of clear cell renal cell carcinoma (ccRCC) based on a six-lncRNA-based risk score: an investigation based on RNA-sequencing data

J Zeng, W Lu, L Liang, G Chen, H Lan, XY Liang… - Journal of translational …, 2019 - Springer
Background The scientific understanding of long non-coding RNAs (lncRNAs) has improved
in recent decades. Nevertheless, there has been little research into the role that lncRNAs …

Genome‐wide screening and cohorts validation identifying novel lncRNAs as prognostic biomarkers for clear cell renal cell carcinoma

C Zhang, D Huang, A Liu, Y Xu, R Na… - Journal of Cellular …, 2020 - Wiley Online Library
Abstracts Clear cell renal cell carcinoma (ccRCC) is the main subtype of renal cell
carcinoma with varied prognosis. We aimed to identify and assess the possible prognostic …

[HTML][HTML] Development and interpretation of a genomic instability derived lncRNAs based risk signature as a predictor of prognosis for clear cell renal cell carcinoma …

H Yang, X Xiong, H Li - Frontiers in oncology, 2021 - frontiersin.org
Background Clear cell renal cell carcinoma (ccRCC) is a kind of frequently diagnosed
cancer, leading to high death rate in patients. Genomic instability (GI) is regarded as playing …

[HTML][HTML] A Novel Tumor Mutation Burden Related lncRNA Signature Identified Prognosis and Tumor Immune Microenvironment Features in Clear Cell Renal Cell …

L Lin, XH Wu, JM Zhu, SH Chen, YH Chen… - … Chemistry & High …, 2023 - ncbi.nlm.nih.gov
Background Emerging evidence indicates that long noncoding RNA (lncRNA) plays an
important biological role in clear cell renal cell carcinoma (ccRCC); however, the clinical …

[HTML][HTML] Development of a TGF-β signaling-related genes signature to predict clinical prognosis and immunotherapy responses in clear cell renal cell carcinoma

X Wu, W Xie, B Gong, B Fu, W Chen, L Zhou… - Frontiers in …, 2023 - frontiersin.org
Background Transforming growth factor (TGF)-β signaling is strongly related to the
development and progression of tumor. We aimed to construct a prognostic gene signature …

[HTML][HTML] A novel machine learning 13-gene signature: Improving risk analysis and survival prediction for clear cell renal cell carcinoma patients

P Terrematte, DS Andrade, J Justino, B Stransky… - Cancers, 2022 - mdpi.com
Simple Summary Clear cell renal cell carcinoma is a type of kidney cancer which comprises
the majority of all renal cell carcinomas. Many efforts have been made to identify biomarkers …

[HTML][HTML] Identification of a three-glycolysis-related lncRNA signature correlated with prognosis and metastasis in clear cell renal cell carcinoma

T Li, H Tong, J Zhu, Z Qin, S Yin, Y Sun, X Liu… - Frontiers in …, 2022 - frontiersin.org
Clear cell renal cell carcinoma (ccRCC) is a malignant disease and an energy metabolic
disease. We aimed to identify a novel prognostic model based on glycolysis-related …

[HTML][HTML] Chromatin regulators-related lncRNA signature predicting the prognosis of kidney renal clear cell carcinoma and its relationship with immune …

X Zhang, X Qin, T Yu, K Wang, Y Chen, Q Xing - Frontiers in Genetics, 2022 - frontiersin.org
Background: Kidney Renal Clear cell carcinoma (KIRC) is a major concern in the urinary
system. A lot of researches were focused on Chromatin Regulators (CRs) in tumors. In this …